Cafe Sci Cambridge: Making your medicines personal: is it all in your genes?

Why do some people respond better to certain medicines than others? Discover how we’re using information from our genes linked to clinical trials of new medicines to understand this.
Wed 10th Apr,
7:00pm to 8:30pm

Emma Davenport is a Group Leader at the Wellcome Sanger Institute, Cambridge. Her group focuses on how genetics contributes to patient-to-patient heterogeneity within disease and in response to treatment. Emma conducted her postdoctoral research at Brigham and Women’s Hospital, Harvard Medical School and the Broad Institute. There she developed a statistical framework to investigate how the administration of a drug alters the relationship between genomic variation and gene expression. Emma completed her PhD at the University of Oxford. She investigated the genetic determinants of variation in the human response to common and rare infection, focusing on sepsis and common variable immunodeficiency disorders.


This is a free and non-ticketed event.
Doors open at 18:45 so arrive early to avoid disappointment.
Starts at 19:00 and finish around 20:30.